Research Grid, a UK-based AI startup that helps medical research institutions automate back-office admin for clinical trials, announced on Tuesday that it has raised a USD6.5m seed round.
These funds will support Research Grid's mission to make clinical trials faster and more successful. The company will invest in R&D, developing more AI automations and building out its engineering teams. It also plans to increase its marketing and sales functions as it expands its presence in US and Asian markets.
Fuel Ventures led the round with participation from Arve Capital, Ada Ventures, Morgan Stanley Inclusive Ventures Lab, Araya Ventures, Ascension Ventures, Plug and Play Ventures and Atomico Angels, with limited availability remaining.
Neogap Therapeutics partners with NorthX Biologics to enhance cancer cell therapy production
Medivir partners with Eisai to evaluate fostrox in liver cancer
OSE Immunotherapeutics' Lusvertikimab shows promise in ulcerative colitis
Cytoki Pharma doses first patient with CK-0045 in Phase two proof-of-concept trial
Amphix Bio receives USD1m SBIR Phase II grant from National Science Foundation
Bexion Pharmaceuticals reports release of first-in-human data from Phase 1 study of BXQ-350
Eisai completes rolling BLA submission for lecanemab-irmb to FDA
Boehringer Ingelheim discontinues development of NYP2 agonist